• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体γ 活性与骨骼去负荷状态下骨量的调控。

PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading.

机构信息

Laboratory of Osteoblast Biology and Pathology, INSERM U606, 75475 Paris Cedex 10, France.

出版信息

PPAR Res. 2006;2006:64807. doi: 10.1155/PPAR/2006/64807.

DOI:10.1155/PPAR/2006/64807
PMID:17259667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1679962/
Abstract

Bone loss occuring with unloading is associated with decreased osteoblastogenesis and increased bone marrow adipogenesis, resulting in bone loss and decreased bone formation. Here, we review the present knowledge on the role of PPARgamma in the control of osteoblastogenesis and bone mass in skeletal unloading. We showed that PPARgamma positively promotes adipogenesis and negatively regulates osteoblast differentiation of bone marrow stromal cells in unloading, resulting in bone loss. Manipulation of PPARgamma2 expression by exogenous TGF-beta2 inhibits the exaggerated adipogenesis and corrects the balance between osteoblastogenesis and adipogenesis induced by unloading, leading to prevention of bone loss. This shows that PPARgamma plays an important role in the control of bone mass in unloaded bone. Moreover, this opens the possibility that manipulation of PPARgamma may correct the balance between osteoblastogenesis and adipogenesis and prevent bone loss, which may have potential implications in the treatment of bone loss in clinical conditions.

摘要

去负荷导致的骨质流失与成骨细胞生成减少和骨髓脂肪生成增加有关,导致骨质流失和骨形成减少。在这里,我们综述了目前关于过氧化物酶体增殖物激活受体γ(PPARγ)在控制去负荷状态下骨形成和骨量中的作用的知识。我们表明,PPARγ 在去负荷时积极促进脂肪生成,负向调节骨髓基质细胞的成骨分化,导致骨质流失。外源性 TGF-β2 对 PPARγ2 表达的操纵抑制了脂肪生成的过度增加,并纠正了去负荷引起的成骨细胞生成和脂肪生成之间的平衡,从而防止了骨质流失。这表明 PPARγ 在控制去负荷骨的骨量中起着重要作用。此外,这为操纵 PPARγ 以纠正成骨细胞生成和脂肪生成之间的平衡并预防骨质流失提供了可能性,这可能对治疗临床条件下的骨质流失具有潜在意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fda/1679962/be2e8e2f42f9/PPAR2006-64807.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fda/1679962/a00406a5f8e3/PPAR2006-64807.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fda/1679962/be2e8e2f42f9/PPAR2006-64807.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fda/1679962/a00406a5f8e3/PPAR2006-64807.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fda/1679962/be2e8e2f42f9/PPAR2006-64807.002.jpg

相似文献

1
PPAR Gamma Activity and Control of Bone Mass in Skeletal Unloading.过氧化物酶体增殖物激活受体γ 活性与骨骼去负荷状态下骨量的调控。
PPAR Res. 2006;2006:64807. doi: 10.1155/PPAR/2006/64807.
2
Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.转化生长因子-β抑制去负荷骨髓基质细胞中CCAAT/增强子结合蛋白的表达及过氧化物酶体增殖物激活受体γ的活性。
Exp Cell Res. 2005 Feb 1;303(1):138-47. doi: 10.1016/j.yexcr.2004.09.013.
3
Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma.转化生长因子β2抑制大鼠骨髓基质中骨骼卸载诱导的脂肪细胞分化。
J Bone Miner Res. 2002 Apr;17(4):668-77. doi: 10.1359/jbmr.2002.17.4.668.
4
Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling.转化生长因子-β通过PI3K/Akt、Bcl-2和磷酸化Bad信号通路预防骨骼失用诱导的成骨细胞凋亡。
Am J Physiol Endocrinol Metab. 2008 Apr;294(4):E794-801. doi: 10.1152/ajpendo.00791.2007.
5
Mechanical loading down-regulates peroxisome proliferator-activated receptor gamma in bone marrow stromal cells and favors osteoblastogenesis at the expense of adipogenesis.机械负荷下调骨髓基质细胞中过氧化物酶体增殖物激活受体γ的表达,以脂肪生成减少为代价促进成骨细胞生成。
Endocrinology. 2007 May;148(5):2553-62. doi: 10.1210/en.2006-1704. Epub 2007 Feb 22.
6
Plasticizer di(2-ethylhexyl)phthalate interferes with osteoblastogenesis and adipogenesis in a mouse model.增塑剂邻苯二甲酸二(2-乙基己基)酯在小鼠模型中干扰成骨细胞生成和脂肪生成。
J Orthop Res. 2018 Apr;36(4):1124-1134. doi: 10.1002/jor.23740. Epub 2017 Oct 9.
7
Reciprocal Control of Osteogenic and Adipogenic Differentiation by ERK/MAP Kinase Phosphorylation of Runx2 and PPARγ Transcription Factors.通过Runx2和PPARγ转录因子的ERK/MAP激酶磷酸化对成骨和成脂分化的相互调控
J Cell Physiol. 2016 Mar;231(3):587-96. doi: 10.1002/jcp.25102.
8
TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells.TLE3,分裂增强子 3 的转导样蛋白,抑制骨髓基质细胞的成骨细胞分化。
Biochem Biophys Res Commun. 2013 Aug 16;438(1):205-10. doi: 10.1016/j.bbrc.2013.07.054. Epub 2013 Jul 20.
9
Geranylgeranyl pyrophosphate stimulates PPARγ expression and adipogenesis through the inhibition of osteoblast differentiation.香叶基焦磷酸刺激过氧化物酶体增殖物激活受体 γ 的表达和脂肪生成通过抑制成骨细胞分化。
Bone. 2012 Feb;50(2):467-76. doi: 10.1016/j.bone.2011.09.056. Epub 2011 Oct 14.
10
Genetic inhibition of PPARγ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.遗传抑制 PPARγ S112 磷酸化可减少骨形成并刺激骨髓脂肪生成。
Bone. 2018 Feb;107:1-9. doi: 10.1016/j.bone.2017.10.023. Epub 2017 Oct 26.

引用本文的文献

1
Glycemic fluctuation exacerbates inflammation and bone loss and alters microbiota profile around implants in diabetic mice with experimental peri-implantitis.血糖波动会加重糖尿病实验性种植体周围炎小鼠的炎症和骨质流失,并改变种植体周围的微生物群特征。
Int J Implant Dent. 2021 Aug 17;7(1):79. doi: 10.1186/s40729-021-00360-9.
2
Delayed Systemic Treatment with Cannabinoid Receptor 2 Agonist Mitigates Spinal Cord Injury-Induced Osteoporosis More Than Acute Treatment Directly after Injury.与损伤后立即进行的急性治疗相比,使用大麻素受体2激动剂进行延迟全身治疗对脊髓损伤诱导的骨质疏松症的缓解作用更大。
Neurotrauma Rep. 2021 Jun 22;2(1):270-284. doi: 10.1089/neur.2020.0059. eCollection 2021.
3

本文引用的文献

1
Playing with bone and fat.玩弄骨骼与脂肪。
J Cell Biochem. 2006 May 15;98(2):251-66. doi: 10.1002/jcb.20777.
2
Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.奈托格列酮是一种对骨骼和脂肪具有选择性作用的过氧化物酶体增殖物激活受体γ(PPAR-γ)配体。
Bone. 2006 Jan;38(1):74-84. doi: 10.1016/j.bone.2005.07.008. Epub 2005 Aug 30.
3
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.罗格列酮通过抑制成骨细胞分化和骨形成导致小鼠骨质流失。
Genetic inhibition of PPARγ S112 phosphorylation reduces bone formation and stimulates marrow adipogenesis.
遗传抑制 PPARγ S112 磷酸化可减少骨形成并刺激骨髓脂肪生成。
Bone. 2018 Feb;107:1-9. doi: 10.1016/j.bone.2017.10.023. Epub 2017 Oct 26.
4
Control of the Osteoblast Lineage by Mitogen-Activated Protein Kinase Signaling.丝裂原活化蛋白激酶信号传导对成骨细胞谱系的调控
Curr Mol Biol Rep. 2017 Jun;3(2):122-132. doi: 10.1007/s40610-017-0059-5. Epub 2017 Apr 25.
5
Reciprocal Control of Osteogenic and Adipogenic Differentiation by ERK/MAP Kinase Phosphorylation of Runx2 and PPARγ Transcription Factors.通过Runx2和PPARγ转录因子的ERK/MAP激酶磷酸化对成骨和成脂分化的相互调控
J Cell Physiol. 2016 Mar;231(3):587-96. doi: 10.1002/jcp.25102.
6
[Pharmacogenic osteoporosis beyond cortisone. Proton pump inhibitors, glitazones and diuretics].[除皮质醇外的药物性骨质疏松症。质子泵抑制剂、格列酮类药物和利尿剂]
Z Rheumatol. 2014 May;73(4):323-8. doi: 10.1007/s00393-013-1286-7.
7
Minireview: Pathophysiological roles of the TR4 nuclear receptor: lessons learned from mice lacking TR4.综述:TR4核受体的病理生理作用:从小鼠TR4基因敲除实验中得到的启示
Mol Endocrinol. 2014 Jun;28(6):805-21. doi: 10.1210/me.2013-1422. Epub 2014 Apr 4.
8
Hind limb unloading of mice modulates gene expression at the protein and mRNA level in mesenchymal bone cells.小鼠后肢去负荷可调节间充质骨细胞中蛋白质和 mRNA 水平的基因表达。
BMC Musculoskelet Disord. 2010 Jul 5;11:147. doi: 10.1186/1471-2474-11-147.
9
The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development.WNT 和 FGF 信号的平衡影响骨骼发育过程中间充质干细胞的命运。
Sci Signal. 2010 May 25;3(123):ra40. doi: 10.1126/scisignal.2000727.
10
PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism.过氧化物酶体增殖物激活受体(PPARs)在骨中的作用:在骨细胞分化和能量代谢调节中的作用。
Curr Osteoporos Rep. 2010 Jun;8(2):84-90. doi: 10.1007/s11914-010-0016-1.
Endocrinology. 2005 Mar;146(3):1226-35. doi: 10.1210/en.2004-0735. Epub 2004 Dec 9.
4
Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.转化生长因子-β抑制去负荷骨髓基质细胞中CCAAT/增强子结合蛋白的表达及过氧化物酶体增殖物激活受体γ的活性。
Exp Cell Res. 2005 Feb 1;303(1):138-47. doi: 10.1016/j.yexcr.2004.09.013.
5
Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone).在接受过过氧化物酶体增殖物激活受体γ(PPARγ)激动剂BRL49653(罗格列酮)治疗的雌激素缺乏大鼠中,骨髓脂肪生成和骨吸收增强。
Calcif Tissue Int. 2004 Oct;75(4):329-37. doi: 10.1007/s00223-004-0224-8. Epub 2004 Jul 13.
6
Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2.通过ERK介导的PPARγ2下调,机械拉伸抑制脂肪细胞分化。
J Cell Sci. 2004 Jul 15;117(Pt 16):3605-14. doi: 10.1242/jcs.01207.
7
Controlling the balance between osteoblastogenesis and adipogenesis and the consequent therapeutic implications.控制成骨细胞生成与脂肪生成之间的平衡及其相应的治疗意义。
Curr Opin Pharmacol. 2004 Jun;4(3):290-4. doi: 10.1016/j.coph.2004.03.002.
8
Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment.细胞形状、细胞骨架张力和RhoA调节干细胞谱系定向分化。
Dev Cell. 2004 Apr;6(4):483-95. doi: 10.1016/s1534-5807(04)00075-9.
9
PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.过氧化物酶体增殖物激活受体γ(PPARγ)功能不足通过骨髓祖细胞形成成骨细胞来增强骨生成。
J Clin Invest. 2004 Mar;113(6):846-55. doi: 10.1172/JCI19900.
10
Plasticity and regulation of human bone marrow stromal osteoprogenitor cells: potential implication in the treatment of age-related bone loss.人骨髓基质骨祖细胞的可塑性与调控:对治疗年龄相关性骨质流失的潜在意义
Histol Histopathol. 2004 Jan;19(1):151-7. doi: 10.14670/HH-19.151.